Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
With
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Mild to Moderate hypertension (90mmHg\<DBP\<110mmHg and 140mmHg\<SBP\<180mmHg)
Or new diagnosed hypertension (after 2 visits within 1 month), never treated before and responding to required conditions for a treatment with irbesartan, after an adapted but insufficient diet
Or a patient having already been treated with a non-satisfying antihypertensive treatment stopped since at least 2 weeks before the inclusion
A minimum exam labs as required by WHO-ISH within the month before the inclusion
You may not be if
Severe Arterial Hypertension (PAS \> than or = to 180 mm Hg or PAD \> than or = to 110 mmHg)
Isolated Systolic Hypertension
Secondary Hypertension
Bilateral renal arterial stenosis or renal arterial stenosis
Non surgically sterilised woman or non post-menopausal woman
Confirmed sodium depletion
Irbesartan hypersensitivity
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.